TuHURA Biosciences/$HURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TuHURA Biosciences
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Ticker
$HURA
Sector
Primary listing
Employees
22
Headquarters
Website
HURA Metrics
BasicAdvanced
$141m
-
-$0.59
-
-
Price and volume
Market cap
$141m
52-week high
$3.90
52-week low
$0.41
Average daily volume
526k
Financial strength
Current ratio
1.151
Quick ratio
1.066
Long term debt to equity
1.078
Total debt to equity
1.97
Interest coverage (TTM)
-44.47%
Profitability
EBITDA (TTM)
-28.968
Management effectiveness
Return on assets (TTM)
-81.88%
Return on equity (TTM)
-187.16%
Valuation
Price to book
6.16
Price to tangible book (TTM)
11.59
Price to free cash flow (TTM)
-4.22
Free cash flow yield (TTM)
-23.69%
Free cash flow per share (TTM)
-0.526
Growth
Earnings per share change (TTM)
-35.76%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs